Simvastatin for the prevention and treatment of delirium in critically ill, mechanically ventilated patients (MoDUS): a cost-effectiveness analysis

Ashley Agus, Glenn Phair, Valerie J. Page, Danny F. McAuley

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)e9-e10
JournalThe Lancet Respiratory Medicine
Volume6
Issue number3
Early online date26 Feb 2018
DOIs
Publication statusPublished - Mar 2018

Cite this

@article{b10c4b89858444c48494e7f35e13bbe3,
title = "Simvastatin for the prevention and treatment of delirium in critically ill, mechanically ventilated patients (MoDUS): a cost-effectiveness analysis",
author = "Ashley Agus and Glenn Phair and Page, {Valerie J.} and McAuley, {Danny F.}",
year = "2018",
month = "3",
doi = "10.1016/S2213-2600(18)30070-5",
language = "English",
volume = "6",
pages = "e9--e10",
journal = "The Lancet Respiratory Medicine",
issn = "2213-2600",
publisher = "Elsevier Limited",
number = "3",

}

Simvastatin for the prevention and treatment of delirium in critically ill, mechanically ventilated patients (MoDUS): a cost-effectiveness analysis. / Agus, Ashley; Phair, Glenn; Page, Valerie J.; McAuley, Danny F.

In: The Lancet Respiratory Medicine, Vol. 6, No. 3, 03.2018, p. e9-e10.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Simvastatin for the prevention and treatment of delirium in critically ill, mechanically ventilated patients (MoDUS): a cost-effectiveness analysis

AU - Agus, Ashley

AU - Phair, Glenn

AU - Page, Valerie J.

AU - McAuley, Danny F.

PY - 2018/3

Y1 - 2018/3

UR - http://www.scopus.com/inward/record.url?scp=85042618022&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(18)30070-5

DO - 10.1016/S2213-2600(18)30070-5

M3 - Letter

C2 - 29508709

AN - SCOPUS:85042618022

VL - 6

SP - e9-e10

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

SN - 2213-2600

IS - 3

ER -